scispace - formally typeset
A

Alice Nennecke

Researcher at Istituto Superiore di Sanità

Publications -  40
Citations -  5574

Alice Nennecke is an academic researcher from Istituto Superiore di Sanità. The author has contributed to research in topics: Population & Relative survival. The author has an hindex of 17, co-authored 36 publications receiving 3871 citations.

Papers
More filters
Journal ArticleDOI

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Claudia Allemani, +594 more
- 17 Mar 2018 - 
TL;DR: For most cancers, 5-year net survival remains among the highest in the world in the USA and Canada, in Australia and New Zealand, and in Finland, Iceland, Norway, and Sweden, while for many cancers, Denmark is closing the survival gap with the other Nordic countries.
Journal ArticleDOI

Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study

TL;DR: The major advances in cancer management that occurred up to 2007 seem to have resulted in improved survival in Europe, although results for lung cancer in some regions (central and eastern Europe) might be affected by overestimation.
Journal ArticleDOI

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

Gemma Gatta, +134 more
- 01 Aug 2017 - 
TL;DR: The estimates of the burden of rare cancers in Europe, their time trends in incidence and survival, and information about centralisation of treatments in seven European countries are updated to help improve case management and survival.
Journal ArticleDOI

Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries.

Audrey Bonaventure, +508 more
TL;DR: Global inequalities in survival from childhood leukaemia have narrowed with time but remain very wide for both ALL and AML, which provides useful information for health policy makers on the effectiveness of health-care systems and for cancer policy makers to reduce inequalities in childhood cancer survival.
Journal ArticleDOI

Sex Differences in Colorectal Cancer Survival: Population-Based Analysis of 164,996 Colorectal Cancer Patients in Germany

TL;DR: A survival advantage of female compared to male CRC patients, most notably in young and middle aged patients and patients with localized disease, is confirmed in a large population-based study.